News
Press Release
Edwards Announces 6-Month Pascal Results – Eyes MitraClip Market
PARIS, May 22, 2019 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the
FDA Expands MitraClip Indication Post-COAPT Trial – For Patients who develop heart failure symptoms and moderate-to-severe or severe mitral regurgitation when combined with optimal medical therapy.
Read Full Article here: https://www.medtechdive.com/news/abbott-gains-expanded-indication-for-mitraclip-valve-repair-device/550580/
A meta-analysis of the COAPT and MITRA-FR Results changes the way we look at MR & the LV in heart failure.
Silicon Valley, December, 2018 – Proportionate and Disproportionate Functional Mitral Regurgitation A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials Paul A. Grayburn, Anna Sannino and Milton Packer Read full article here: http://imaging.onlinejacc.org/content/early/2018/11/28/j.jcmg.2018.11.006
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Silicon Valley, September, 2018 – COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF. Physicians responded with shock and excitement to findings, but struggled to reconcile the results with the MITRA-FR trial. Read article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1806640 Gregg W. Stone, M.D. et al. for the COAPT Investigators*
Mitre Medical Corp. to Present a Beating Heart Option for Functional MR Repair and Will Present 6-Month Results from the ENRAPT-MR Trial at Two Upcoming European Cardiac Surgery Conferences.
Silicon Valley, September 7, 2018 –Mitre Medical has been invited to introduce the Mitral Touch epicardial annuloplasty system that enables a beating heart option for the surgical treatment of mitral regurgitation during the 9 September Innovator’s Day poster session, as part of the PCR London Valves meeting, to be held
MITRA-FR Misses All End Points for MitraClip in HF Patients
Silicon Valley, August, 2018 – Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Jean-François Obadia, M.D. et al., for the MITRA-FR Investigators* Read full article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1805374
AngioConsult strengthens the cooperation with Mitre Medical Corp. with the addition of Andrew Kim to the team.
Speyer/Silicon Valley, 05/08/2018 – AngioConsult announces the strengthening of the cooperation with Mitre Medical Corp. with the addition of Andrew Kim to the team. Andrew is the second representative of AngioConsult supporting the medical device company, which is based in Silicon Valley, California. Benjamin Rieck, Sr Managing Partner of the